Trazodone Tapering Recommendations
When discontinuing trazodone after more than a few days of use, gradually reduce the dose by the smallest increment possible over successive steps of at least several days' duration, with successful tapering potentially requiring several weeks to months. 1
Tapering Strategy
General Principles
Gradual dose reduction is essential to minimize rebound insomnia (worsening of symptoms lasting 1-3 days), physical withdrawal effects, and psychological withdrawal symptoms that can occur upon discontinuation 1
The FDA label explicitly recommends gradually reducing the dosage rather than stopping trazodone abruptly whenever possible 2
Taper at a very slow rate based on case reports demonstrating withdrawal symptoms can develop despite gradual discontinuation, likely due to trazodone's short half-life and effects on the serotonergic system causing noradrenergic rebound 3
Specific Tapering Approach
Dose reduction method:
- Lower the dose by the smallest increment possible (typically 25-50 mg decrements for trazodone given its available tablet strengths) 1
- Allow at least several days between each dose reduction step 1
- The entire tapering process may require several weeks to months to complete successfully 1
Frequency tapering alternative:
- Tapering the frequency of administration (such as every other or every third night) has been shown to minimize rebound effects for hypnotic medications generally 1
- However, recent evidence strongly suggests avoiding alternate-day dosing as this approach risks severe withdrawal effects due to pronounced increases in receptor occupancy variation, even at low doses 4
Important Clinical Considerations
Concurrent Cognitive-Behavioral Therapy
- Tapering and discontinuation is significantly facilitated by concurrent application of cognitive-behavioral therapies, which increase rates of successful discontinuation and duration of abstinence 1
Context: Trazodone's Limited Evidence Base
- The VA/DoD guidelines advise against using trazodone for chronic insomnia due to low-quality efficacy evidence that is outweighed by its adverse effect profile 5
- Systematic reviews showed trazodone (50-150 mg) had no differences versus placebo in sleep efficiency or discontinuation rates due to adverse events, with only subjective sleep quality improvement 5
Patient Education
- Advise patients not to abruptly discontinue trazodone and to discuss any tapering regimen with their healthcare provider 2
- Inform patients that adverse reactions can occur when trazodone is discontinued 2
Common Pitfalls to Avoid
- Do not use alternate-day dosing as a tapering strategy, despite its common clinical use, as this creates significant receptor occupancy fluctuations that increase withdrawal risk 4
- Do not minimize withdrawal symptoms as simply a relapse of the underlying condition; healthcare professionals must adopt a reassuring yet non-minimizing approach 6
- Do not rush the taper; the very slow rate recommendation is based on trazodone's pharmacokinetic properties that predispose to withdrawal 3